Sign in
MCUJF Stock Price, Chart, Stats & News
Medicure Inc.
Save
Medicure Inc. (MCUJF) does not currently pay a dividend.
10.02M
Market cap
–
Current P/E
13.14x
Forward P/E
MCUJF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Drug Manufacturers - Specialty & Generic
Industry
Medicure Inc. operates as a biopharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for the cardiovascular market, primarily serving Canada and the United States. Among its key offerings is AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist specifically designed to manage acute coronary syndrome, encompassing conditions like unstable angina and non-Q-wave myocardial infarction. The company also distributes ZYPITAMAG, a medication aimed at treating patients suffering from primary hyperlipidemia or mixed dyslipidemia.
Similar securities
Based on sector and market capitalization
Report issue